A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer

By Vrou Offersen Birgitte   Alsner Jan   Ege Olsen Karen   Riisbro Rikke   Brunner Nils   Brandt Sørensen Flemming   Sandahl Sørensen Boe   Olrik Schlemmer Birgitte   Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 618-632

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

By Powell B.L.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 65-68

Springer Publishing Company

Access to resources Recommend Favorite

Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients

By Tan Xiang-Lin   Popanda Odilia   Ambrosone Christine   Kropp Silke   Helmbold Irmgard   Fournier Dietrich   Haase Wulf   Sautter-Bihl Marie   Wenz Frederik   Schmezer Peter   Chang-Claude Jenny  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution

By                  

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 363-369

Spandidos Publications

Access to resources Recommend Favorite